top of page
The Way Forward Is Clearer, Together.
The Women’s Cancer Research Foundation (WCRF) annually publishes and funds numerous clinical studies on breast and gynecologic (ovarian, endometrial, and cervical) cancers. The WCRF’s oncology experts work tirelessly with the belief that each new clinical study has the potential to fundamentally improve the outcomes of patients diagnosed with breast and gynecologic cancers.
New Drug Combination Shown to be Effective for Patients with Advanced Ovarian Cancer
Ovarian cancer is the most lethal gynecologic malignancy. Novel approaches for relapsed ovarian cancer are necessary to improve survival.
Women's Cancer Research Foundation
Apr 25, 20222 min read
0 comments
Lighting the Way for Improved Detection of Ovarian Cancer
Pafolacianine, an imaging drug that can help surgeons identify ovarian cancer lesions, has recently been accorded FDA approval.
Women's Cancer Research Foundation
Apr 19, 20221 min read
0 comments
Breast Cancer Surveillance Following Ovarian Cancer in BRCA Mutation Carriers
Women with a BRCA 1 or 2 mutation carriers have an increased risk of developing breast cancer and ovarian cancer. However....
Women's Cancer Research Foundation
Mar 28, 20221 min read
0 comments
A Novel Treatment For Platinum-Resistant Ovarian Cancer
Every year in the U.S., 22,000 to 24,000 women are diagnosed with ovarian cancer. Patient survival depends upon the responses to...
Women's Cancer Research Foundation
Mar 22, 20221 min read
0 comments
Racial Disparities in Non-Recommendation of Adjuvant Chemotherapy in Ovarian Cancer
In a recent study from Gynecologic Oncology, the authors identified ovarian cancer patients who underwent primary surgery from 2004 to 2015.
Women's Cancer Research Foundation
Mar 16, 20221 min read
0 comments
Overall Survival and Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer
In a recent JAMA study, researchers endeavored to determine if there were differences in overall survival among ovarian cancer patients...
Women's Cancer Research Foundation
Mar 10, 20221 min read
0 comments
Why Black Women with Ovarian Cancer Require Greater Focus
While mortality due to ovarian cancer is decreasing overall, Black women continue to have lower survival rates and higher rates of disease..
Women's Cancer Research Foundation
Mar 8, 20222 min read
0 comments
Ovarian Cancer Update
Last year, an estimated 314,000 people worldwide developed ovarian cancer, a condition associated with a 50% mortality rate.
Women's Cancer Research Foundation
Mar 2, 20221 min read
0 comments
Sugary Food and Beverage Consumption and the Risk of Developing Ovarian Cancer
Select researchers have inquired if refined sugars contribute to the manifestation of Ovarian Cancer.
Women's Cancer Research Foundation
Feb 9, 20221 min read
0 comments
Do Annual Screenings Reduce Risk of Death in Ovarian Cancer?
Ovarian cancer is an aggressive disease, with a 10-year survival rate of 35%.
Women's Cancer Research Foundation
Nov 5, 20212 min read
0 comments
Intrauterine Device May Reduce Ovarian Cancer Risk by 30%
Women who have ever used an intrauterine device (IUD) for birth control may have a 30% lower risk for ovarian cancer.
Women's Cancer Research Foundation
Nov 3, 20211 min read
0 comments
Genital Powder Use and Epithelial Ovarian Cancer
Beginning in 2014, several lawsuits were filed against companies with talc products (baby powder) on behalf of women with ovarian cancer.
Women's Cancer Research Foundation
Oct 30, 20212 min read
0 comments
No Survival Benefit from Annual Ovarian Cancer Screening in Low-Risk Women
The lifetime risk of developing ovarian cancer in women who are not genetically susceptible to the disease is approximately 2%.
Women's Cancer Research Foundation
Oct 27, 20212 min read
0 comments
Oral Contraceptives May Reduce Risk of Ovarian Cancer in BRCA Carriers
Analyses showed a longer duration of contraceptive use and more recent use were associated with a greater reduction in ovarian cancer risk.
Women's Cancer Research Foundation
Oct 22, 20211 min read
0 comments
Use of Hair Products in Relation to Ovarian Cancer Risk
In 2021 study conducted, the authors evaluated the potential impact of carcinogens from hair products that may be absorbed into bloodstream.
Women's Cancer Research Foundation
Sep 20, 20211 min read
0 comments
Association Between Breastfeeding and Ovarian Cancer Risk
The results from several oncology studies have indicated that breastfeeding is associated with a reduced risk of epithelial ovarian cancer.
Women's Cancer Research Foundation
Sep 3, 20211 min read
0 comments
Women With Ovarian Cancer at Higher Risk for Mental Health Disorders
Ovarian cancer survivors who had a mental health diagnosis demonstrated an 80% higher risk for mortality.
Women's Cancer Research Foundation
Aug 31, 20212 min read
0 comments
Time-Dependent Effects of Oral Contraceptive Use on Breast, Ovarian, and Endometrial Cancers
Oral contraceptive use potentially reduces the risk of breast, ovarian, and endometrial cancers.
Women's Cancer Research Foundation
Aug 12, 20211 min read
0 comments
Drug Boosts Survival for Women with Advanced Ovarian Cancer
Lynparza (Olaparib), a targeted cancer therapy, has recently shown a meaningful survival benefit after 5 years.
Women's Cancer Research Foundation
Aug 5, 20211 min read
0 comments
Short-term Impact of Surgically Induced Menopause on Cognitive Function and Wellbeing
The short-term effect of surgically induced menopause on cognitive function and quality of life in women at high risk for ovarian cancer.
Women's Cancer Research Foundation
Jul 27, 20212 min read
0 comments
bottom of page